Quick Answer
BICYCLE THERAPEUTICS PLC reported Common Stock Shares Outstanding of 69.37 million shares for the year ending 2025.
- BICYCLE THERAPEUTICS PLC showed an increase of +0.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from BICYCLE THERAPEUTICS PLC's annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2019: 17.90 million shares | Q3 2019: 17.90 million shares | Q1 2020: 18.02 million shares | Q2 2020: 18.09 million shares | Q3 2020: 20.94 million shares | Q1 2021: 23.52 million shares | Q2 2021: 24.12 million shares | Q3 2021: 25.60 million shares | Q1 2022: 29.64 million shares | Q2 2022: 29.67 million shares | Q3 2022: 29.68 million shares | Q1 2023: 30.03 million shares | Q2 2023: 30.59 million shares | Q3 2023: 42.38 million shares | Q1 2024: 42.63 million shares | Q2 2024: 68.94 million shares | Q3 2024: 69.02 million shares | Q1 2025: 69.20 million shares | Q2 2025: 69.25 million shares | Q3 2025: 69.31 million shares.
- Over the full 8 years of available data (2018 to 2025), BICYCLE THERAPEUTICS PLC's Common Stock Shares Outstanding has grown by 8,414.2%.
- Historical annual values: Fiscal year 2025: 69.37 million shares | Fiscal year 2024: 69.06 million shares | Fiscal year 2023: 42.43 million shares | Fiscal year 2022: 29.87 million shares | Fiscal year 2021: 29.58 million shares | Fiscal year 2020: 21.09 million shares | Fiscal year 2019: 17.99 million shares | Fiscal year 2018: 814,728 shares.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: